Beyond the Coronavirus: China Pharma Market Set to Grow


Every news service globally is focused on COVID-19 (the “coronavirus”) and how it will affect the global population, but what of the Chinese health system itself? How does this sector operate during “normal” times? What will drive and restrain Chinese health markets?


These are some of the questions we have been looking at over the past 6 months.


According to our analysis, the Chinese pharmaceutical sector is set for substantial growth across the next decade as a growing middle class, which has greater access to healthcare, is expected to drive the domestic market significantly. A growing overall population, which is tilted towards the middle aged and elderly, is another factor that will boost Chinese healthcare and pharmaceutical markets.


A summary of the factors driving the China pharma market  can be found in the blog here -


GMR Data produce bespoke and off-the-shelf business reports across the Pharmaceutical, Energy / Utility and IT sectors.

Proud to be an Irish business in the gloabl market place.